Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Discover the MAVIA (Heroes of Mavia) Listing on XT
-
Lotus Technology to Report Unaudited First Half 2024 Financial Results on August 28, 2024
-
Maquia Capital Acquisition Corporation Plans to Trade OTC After Delist from Nasdaq
-
Associa Cares Earmarks $100,000 to Assist Victims of Northern California Wildfires
-
NCLA Amicus Brief in NY Case Against Trump Explains Why NY’s Executive Law Violates Free Speech
-
MEEET Launches Revolutionary Social Discovery App with $5M Turnover in First Week
-
NTG Nordic Transport Group acquires SCHMALZ+SCHÖN Holding GmbH
-
FDA Advisory Committee Votes Favorably that the Data Support Arimoclomol as Effective Treatment for Patients with Niemann-Pick Disease Type C
-
Talen Statement on FERC’s Issuance of a Deficiency Letter Regarding Susquehanna ISA and New Generic Proceeding Initiating a Commissioner-led Technical Conference
-
Avicanna Announces Changes of Auditors
-
Helport AI Limited and Tristar Acquisition I Corp. Announce Closing on Reduced $5.5 Million PIPE Investment Concurrently with Closing of Business Combination
-
Diversified Royalty Corp. Announces August 2024 Cash Dividend and Q2 2024 Earnings Release Date
-
NCLA Helping Acclaimed Chicano Poet Fight San Antonio’s Dismissal of Him in Free Speech Dispute
-
Bluewater Acquisition Corp. and AlphaDelta Management Corp. Announce Termination of LOI
-
Termination of TomaGold’s Option for the Acquisition of Chibougamau’s East Block
-
JOYY Announces Leadership Transition
-
Ocean Power Technologies Issues Stockholder Vote and Meeting Reminder
-
Direct Equity Source Announces Strategic Partnership with AAA Storage to Expand Self-Storage Portfolio
-
NexGold Mining Announces New OTCQX Ticker Symbol
-
Management Update
-
Cornerstone Funds Announce Continuing Monthly Distributions for 2024 and Distribution Percentage for 2025
-
FutureFuel Announces Director Resignation
-
Arhaus Unveils Studio in Peachtree City, Georgia
-
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
-
Cornerstone Funds Announce Continuing Monthly Distributions for 2024 and Distribution Percentage for 2025
-
FutureFuel Announces Director Resignation
-
Tourmaline Bio Presents Phase 2 TRANQUILITY Study Design at American Society of Preventive Cardiology (ASPC) Congress 2024
-
Information regarding the total number of voting rights and total number of shares of the Company as of July 31, 2024
-
TWC Enterprises Limited Announces Second Quarter 2024 Results and Eligible Dividend
-
Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
AvidXchange to Participate in Upcoming Investor Conferences
-
Helport AI Limited and Tristar Acquisition I Corp. Announce Closing of Business Combination and listing on Nasdaq
-
CNL Launches New Nuclear & Emerging Technologies (N2ET) Program to Accelerate Innovative, Next-Generation Technologies
-
CNL Launches New Nuclear & Emerging Technologies (N2ET) Program to Accelerate Innovative, Next-Generation Technologies
-
PennantPark Floating Rate Capital Ltd. Announces Monthly Distribution of $0.1025 per Share
-
PennantPark Investment Corporation Announces Monthly Distribution of $0.08 per Share
-
Taitron Announces Quarterly Cash Dividend
-
electroCore Announces Inducement Grant under NASDAQ Listing Rule 5635(c)(4)
-
JIADE LIMITED Receives Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency
-
Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
-
Infinera Corporation Reports Second Quarter 2024 Financial Results
-
Mulvihill Canadian Bank Enhanced Yield ETF Declares Monthly Distribution
-
Premium Global Income Split Corp. Declares Monthly Distribution
-
S Split Corp. Declares Monthly Distribution
-
Mulvihill U.S. Health Care Enhanced Yield ETF Declares Monthly Distribution
-
Mulvihill Premium Yield Fund Declares Monthly Fund Distribution for Its ETF Class
-
Churchill Resources Announces Completion of $2.5M Private Placement
-
Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
-
Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
